{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:17:42Z","timestamp":1769764662217,"version":"3.49.0"},"reference-count":18,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T00:00:00Z","timestamp":1342656000000},"content-version":"vor","delay-in-days":8235,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[1990,1]]},"abstract":"<jats:p><jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>The injection of 100 or 300 \u03bcg of carrageenin into the mouse paw or pleural cavity produced a delayed inflammatory reaction at 48 h while platelet activating factor (PAF)\u2010induced paw oedema and pleurisy were maximal 30 min after its injection.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The PAF antagonist, WEB 2086, failed to inhibit mouse paw oedema and pleurisy induced by PAF, but reduced the first phase of oedema (1\u20134 h) induced by carrageenin without interfering with the second one (48\u201372 h). In contrast, another structurally\u2010related PAF antagonist, WEB 2170, inhibited dose\u2010dependently both oedema and pleurisy induced by PAF and by carrageenin (48 h).<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Repeated injections of PAF into the mouse paw or pleural cavity led to significant auto\u2010desensitization. The animals desensitized to PAF and injected with carrageenin also displayed a significantly reduced oedema.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Our results suggest that PAF may be involved in the inflammatory response to carrageenin in mice. Furthermore, because the different receptor antagonists displayed distinct effects against PAF itself, different sites for <jats:italic>in vivo<\/jats:italic> interaction of PAF are available and are species\u2010 and drug\u2010dependent.<\/jats:p><\/jats:list-item>\n<\/jats:list><\/jats:p>","DOI":"10.1111\/j.1476-5381.1990.tb14671.x","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T19:00:52Z","timestamp":1342724452000},"page":"164-168","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Differential inhibition by two hetrazepine PAF antagonists of acute inflammation in the mouse"],"prefix":"10.1111","volume":"99","author":[{"given":"Maria G.M.O.","family":"Henriques","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian B.","family":"Weg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia M.R.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia D.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato S.B.","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.B.","family":"Vargaftig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,19]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1985.tb15642.x"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90532-0"},{"key":"e_1_2_1_4_1","first-page":"2","article-title":"Perspectives in platelet activating factor research","volume":"39","author":"BRAQUET P.","year":"1987","journal-title":"Pharmacol. Rev"},{"key":"e_1_2_1_5_1","first-page":"974","article-title":"Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor","volume":"241","author":"CASALS\u2010STENZEL J.","year":"1987","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(86)90297-3"},{"key":"e_1_2_1_7_1","first-page":"261","volume-title":"The Ginkgolides: Chemistry, Biology, Pharmacology and Clinical Perspectives","author":"CORDEIRO R.S.B.","year":"1988"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1979.tb13616.x"},{"key":"e_1_2_1_9_1","first-page":"243","article-title":"Mouse paw oedema. A new model for inflammation","volume":"20","author":"HENRIQUES M.G.M.O.","year":"1987","journal-title":"Brazilian J. Med. Biol. Res"},{"key":"e_1_2_1_10_1","article-title":"Alterations in the lung of the guinea pig induced by platelet activating factor and its inhibition by specific antagonists of the hetrazepine type (WEB 2170 and STY 2108)","author":"HEUER H.","journal-title":"Allergy"},{"key":"e_1_2_1_11_1","first-page":"422","article-title":"Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues","volume":"46","author":"HUMPHREY D.M.","year":"1982","journal-title":"Lab. Invest"},{"key":"e_1_2_1_12_1","first-page":"617","article-title":"Characterization of cutaneous vascular permeability induced by platelet\u2010activating factor in guinea\u2010pigs and rats and its inhibition by platelet\u2010activating factor antagonists","volume":"52","author":"HWANG S.\u2010B.","year":"1985","journal-title":"Lab. Invest"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90636-9"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1989.tb11826.x"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00915823"},{"key":"e_1_2_1_16_1","volume-title":"Statistical Methods applied to Experiments in Agriculture and Biology","author":"SNEDECOR G.W.","year":"1953"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1700720203"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90233-5"},{"key":"e_1_2_1_19_1","first-page":"187","article-title":"Blockade of the inflammatory effects of platelet\u2010activating factor by cyclo\u2010oxygenase inhibitors","volume":"14","author":"VARGAFTIG B.B.","year":"1981","journal-title":"Brazilian J. Med. Biol. Res"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.1990.tb14671.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.1990.tb14671.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:41:35Z","timestamp":1697380895000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.1990.tb14671.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,1]]}},"alternative-id":["10.1111\/j.1476-5381.1990.tb14671.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.1990.tb14671.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,1]]},"assertion":[{"value":"2012-07-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}